Stocks and Investing
Stocks and Investing
Fri, October 2, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, October 1, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, September 30, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, September 29, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, September 28, 2015
Jasper Hellweg Upgraded (VRTX) to Strong Buy on, Sep 28th, 2015
Jasper Hellweg of Argus Research, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Strong Buy on, Sep 28th, 2015.
Jasper has made no other calls on VRTX in the last 4 months.
There are 3 other peers that have a rating on VRTX. Out of the 3 peers that are also analyzing VRTX, 2 agree with Jasper's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Biren Amin of "Jefferies" Initiated at Hold and Held Target at $130 on, Wednesday, September 9th, 2015
- Ying Huang of "B of A Securities" Maintained at Hold with Increased Target to $133 on, Monday, July 6th, 2015
This is the rating of the analyst that currently disagrees with Jasper
- Liisa Bayko of "JMP Securities" Maintained at Buy with Increased Target to $148 on, Thursday, July 30th, 2015